TLR4 Transcription Activity Suppressor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090010902A1
SERIAL NO

11774123

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The object of the invention is to provide a TLR4 transcription factor activity suppressor which suppresses TLR4 transcription factor and is effective in inducing or maintaining remission of ulcerative colitis.A TLR4 transcription factor activity suppressor comprising butyric acid bacteria, a metabolite of butyric acid producing bacteria, a metabolite of butyric acid bacteria, or butyric acid is provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TOA PHARMACEUTICAL COMPANY LTD2-1-11 SASAZUKA SHIBUYA-KU TOKYO 151-0073

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Masuda, Takashi Tokyo , JP 193 1849

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation